Research & Development
Our research strategy addresses therapeutic fields where novel solutions are required to fulfill the needs of companies, research institutes, and health care. Future treatments of patients require that Mode of Action patterns are resolved, therapeutic modalities are tailored to provide optimal treatment and disease progression as well as therapeutic outcomes can be monitored.
A selection of our publications can be found under each research topic.
To realize the concept of Precision Medicine, the use of molecular biomarkers has become an indispensable tool.
Immunological platforms are being developed for evaluation of drug candidates and cell therapy products.
Early preclinical studies highly rely on predictive cell models. Bioneer develops a range of 3D cell models based on human cells combined with gene editing technology.
Bioneer:FARMA develops models for orally administrated drugs including gastro intestinal models and absorption models.
We develop and refine protein manufacturing technologies including downstrean and upstream technologies.
Strategic R&D Collaborations
Bioneer participates in a number of external collaborations in all fields of R&D.
Create new product opportunities
We offer access to essential tools, technology and unique biological resources within cell and molecular biology.